Amphastar Pharmaceuticals, Inc. (AMPH) DCF Valuation

Amphastar Pharmaceuticals, Inc. (AMPH) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Amphastar Pharmaceuticals, Inc. (AMPH) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial future of Amphastar Pharmaceuticals, Inc. (AMPH) with our user-friendly DCF Calculator! Enter your projections for growth, margins, and expenses to determine the intrinsic value of Amphastar Pharmaceuticals, Inc. (AMPH) and enhance your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 322.4 349.8 437.8 499.0 644.4 768.1 915.5 1,091.3 1,300.8 1,550.5
Revenue Growth, % 0 8.53 25.13 13.98 29.14 19.2 19.2 19.2 19.2 19.2
EBITDA 81.5 30.2 111.8 107.5 240.3 181.7 216.6 258.1 307.7 366.7
EBITDA, % 25.27 8.63 25.53 21.54 37.29 23.65 23.65 23.65 23.65 23.65
Depreciation 21.1 25.2 26.8 28.7 41.8 49.3 58.8 70.1 83.5 99.6
Depreciation, % 6.55 7.2 6.11 5.76 6.48 6.42 6.42 6.42 6.42 6.42
EBIT 60.3 5.0 85.0 78.8 198.5 132.4 157.8 188.1 224.2 267.2
EBIT, % 18.72 1.43 19.42 15.78 30.81 17.23 17.23 17.23 17.23 17.23
Total Cash 85.4 105.6 136.7 175.8 256.8 250.3 298.4 355.7 424.0 505.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 45.4 66.0 78.8 88.8 114.9
Account Receivables, % 14.08 18.87 18 17.8 17.84
Inventories 110.5 96.8 92.8 103.6 105.8 184.9 220.4 262.6 313.1 373.2
Inventories, % 34.28 27.68 21.2 20.76 16.42 24.07 24.07 24.07 24.07 24.07
Accounts Payable 25.1 24.4 22.2 20.5 25.4 42.8 51.0 60.8 72.5 86.4
Accounts Payable, % 7.77 6.96 5.07 4.11 3.95 5.57 5.57 5.57 5.57 5.57
Capital Expenditure -41.6 -33.9 -27.5 -24.0 -38.2 -60.8 -72.5 -86.4 -103.0 -122.7
Capital Expenditure, % -12.89 -9.68 -6.27 -4.82 -5.92 -7.92 -7.92 -7.92 -7.92 -7.92
Tax Rate, % 19.73 19.73 19.73 19.73 19.73 19.73 19.73 19.73 19.73 19.73
EBITAT 49.0 1.2 62.8 62.0 159.3 89.4 106.6 127.0 151.4 180.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -102.2 -15.2 51.1 44.2 139.5 -1.8 40.1 47.8 57.0 67.9
WACC, % 7.22 6.61 7.14 7.19 7.21 7.07 7.07 7.07 7.07 7.07
PV UFCF
SUM PV UFCF 163.8
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 71
Terminal Value 2,298
Present Terminal Value 1,633
Enterprise Value 1,796
Net Debt 479
Equity Value 1,317
Diluted Shares Outstanding, MM 53
Equity Value Per Share 24.85

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to develop various scenarios.
  • Real-World Data: Amphastar Pharmaceuticals’ financial data pre-filled to accelerate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.

Key Features

  • Comprehensive AMPH Data: Pre-filled with Amphastar Pharmaceuticals’ historical financials and future projections.
  • Fully Customizable Inputs: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures.
  • Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
  • Scenario Testing: Develop multiple forecast scenarios to evaluate various valuation outcomes.
  • User-Friendly Design: Intuitive, structured, and suitable for both professionals and newcomers.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Amphastar Pharmaceuticals data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Amphastar Pharmaceuticals’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Amphastar Pharmaceuticals, Inc. (AMPH)?

  • Accuracy: Utilizes real Amphastar financials to ensure precise data.
  • Flexibility: Allows users to easily test and adjust inputs as needed.
  • Time-Saving: Eliminate the complexity of creating a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected by CFOs.
  • User-Friendly: Intuitive design makes it accessible for users without advanced financial modeling skills.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for analyzing Amphastar Pharmaceuticals (AMPH).
  • Pharmaceutical Finance Teams: Evaluate valuation scenarios to inform corporate strategies and investments.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Amphastar Pharmaceuticals (AMPH).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to the pharmaceutical sector.
  • Industry Enthusiasts: Gain insights into how pharmaceutical companies like Amphastar (AMPH) are valued within the market.

What the Template Contains

  • Pre-Filled Data: Contains Amphastar Pharmaceuticals' historical financials and projections.
  • Discounted Cash Flow Model: Customizable DCF valuation model with automated calculations.
  • Weighted Average Cost of Capital (WACC): A specific sheet for calculating WACC using tailored inputs.
  • Key Financial Ratios: Examine Amphastar's profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Easily modify revenue growth, profit margins, and tax rates.
  • Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.

No products were found matching.